nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CYP1A2—type 2 diabetes mellitus	0.277	1	CbGaD
Alitretinoin—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0488	0.176	CbGbCtD
Alitretinoin—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0435	0.157	CbGbCtD
Alitretinoin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0332	0.12	CbGbCtD
Alitretinoin—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0314	0.114	CbGbCtD
Alitretinoin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0261	0.0943	CbGbCtD
Alitretinoin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0247	0.0892	CbGbCtD
Alitretinoin—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0216	0.078	CbGbCtD
Alitretinoin—CYP1A2—Losartan—type 2 diabetes mellitus	0.0168	0.0608	CbGbCtD
Alitretinoin—ABCB1—Glyburide—type 2 diabetes mellitus	0.0161	0.0581	CbGbCtD
Alitretinoin—ABCB1—Losartan—type 2 diabetes mellitus	0.0147	0.0532	CbGbCtD
Alitretinoin—Vitamin A—RBP4—type 2 diabetes mellitus	0.00332	0.836	CrCbGaD
Alitretinoin—CRABP1—retina—type 2 diabetes mellitus	0.0021	0.0872	CbGeAlD
Alitretinoin—RXRB—islet of Langerhans—type 2 diabetes mellitus	0.00182	0.0758	CbGeAlD
Alitretinoin—CRABP1—cortex of kidney—type 2 diabetes mellitus	0.00169	0.0703	CbGeAlD
Alitretinoin—RXRA—kidney—type 2 diabetes mellitus	0.00156	0.065	CbGeAlD
Alitretinoin—CRABP2—pancreas—type 2 diabetes mellitus	0.00156	0.0648	CbGeAlD
Alitretinoin—CRABP2—adipose tissue—type 2 diabetes mellitus	0.00141	0.0588	CbGeAlD
Alitretinoin—RXRG—cardiovascular system—type 2 diabetes mellitus	0.0014	0.0583	CbGeAlD
Alitretinoin—RARG—retina—type 2 diabetes mellitus	0.00138	0.0575	CbGeAlD
Alitretinoin—RXRB—pancreas—type 2 diabetes mellitus	0.00128	0.0533	CbGeAlD
Alitretinoin—RXRG—adipose tissue—type 2 diabetes mellitus	0.00124	0.0514	CbGeAlD
Alitretinoin—RARA—kidney—type 2 diabetes mellitus	0.00108	0.0448	CbGeAlD
Alitretinoin—RARG—adipose tissue—type 2 diabetes mellitus	0.00103	0.0429	CbGeAlD
Alitretinoin—RXRA—liver—type 2 diabetes mellitus	0.000987	0.0411	CbGeAlD
Alitretinoin—RARA—adipose tissue—type 2 diabetes mellitus	0.00097	0.0404	CbGeAlD
Alitretinoin—RARB—liver—type 2 diabetes mellitus	0.000887	0.0369	CbGeAlD
Alitretinoin—RXRB—liver—type 2 diabetes mellitus	0.000815	0.0339	CbGeAlD
Alitretinoin—RARA—liver—type 2 diabetes mellitus	0.00068	0.0283	CbGeAlD
Alitretinoin—Acitretin—ALB—type 2 diabetes mellitus	0.000366	0.0922	CrCbGaD
Alitretinoin—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000289	0.012	CbGeAlD
Alitretinoin—Tretinoin—CYP3A4—type 2 diabetes mellitus	0.000283	0.0714	CrCbGaD
Alitretinoin—CYP1A2—liver—type 2 diabetes mellitus	0.000252	0.0105	CbGeAlD
Alitretinoin—ABCB1—retina—type 2 diabetes mellitus	0.000247	0.0103	CbGeAlD
Alitretinoin—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000233	0.00968	CbGeAlD
Alitretinoin—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000209	0.00869	CbGeAlD
Alitretinoin—ABCB1—kidney—type 2 diabetes mellitus	0.000204	0.0085	CbGeAlD
Alitretinoin—ABCB1—pancreas—type 2 diabetes mellitus	0.000203	0.00845	CbGeAlD
Alitretinoin—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000199	0.00828	CbGeAlD
Alitretinoin—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000184	0.00766	CbGeAlD
Alitretinoin—ABCB1—liver—type 2 diabetes mellitus	0.000129	0.00538	CbGeAlD
Alitretinoin—Myalgia—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000307	CcSEcCtD
Alitretinoin—Chest pain—Irbesartan—type 2 diabetes mellitus	7.59e-05	0.000307	CcSEcCtD
Alitretinoin—Shock—Metformin—type 2 diabetes mellitus	7.59e-05	0.000307	CcSEcCtD
Alitretinoin—Insomnia—Orlistat—type 2 diabetes mellitus	7.57e-05	0.000306	CcSEcCtD
Alitretinoin—Malaise—Losartan—type 2 diabetes mellitus	7.57e-05	0.000306	CcSEcCtD
Alitretinoin—Anxiety—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000306	CcSEcCtD
Alitretinoin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.56e-05	0.000306	CcSEcCtD
Alitretinoin—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.56e-05	0.000306	CcSEcCtD
Alitretinoin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.55e-05	0.000305	CcSEcCtD
Alitretinoin—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.55e-05	0.000305	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.54e-05	0.000305	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.54e-05	0.000305	CcSEcCtD
Alitretinoin—Somnolence—Valsartan—type 2 diabetes mellitus	7.53e-05	0.000305	CcSEcCtD
Alitretinoin—Syncope—Losartan—type 2 diabetes mellitus	7.53e-05	0.000304	CcSEcCtD
Alitretinoin—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.51e-05	0.000304	CcSEcCtD
Alitretinoin—Discomfort—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000303	CcSEcCtD
Alitretinoin—Skin disorder—Metformin—type 2 diabetes mellitus	7.49e-05	0.000303	CcSEcCtD
Alitretinoin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.46e-05	0.000302	CcSEcCtD
Alitretinoin—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.45e-05	0.000302	CcSEcCtD
Alitretinoin—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.43e-05	0.0003	CcSEcCtD
Alitretinoin—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.43e-05	0.0003	CcSEcCtD
Alitretinoin—Palpitations—Losartan—type 2 diabetes mellitus	7.42e-05	0.0003	CcSEcCtD
Alitretinoin—Nausea—Glimepiride—type 2 diabetes mellitus	7.39e-05	0.000299	CcSEcCtD
Alitretinoin—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000299	CcSEcCtD
Alitretinoin—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.38e-05	0.000298	CcSEcCtD
Alitretinoin—Nausea—Sitagliptin—type 2 diabetes mellitus	7.37e-05	0.000298	CcSEcCtD
Alitretinoin—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.37e-05	0.000298	CcSEcCtD
Alitretinoin—Asthenia—Glyburide—type 2 diabetes mellitus	7.37e-05	0.000298	CcSEcCtD
Alitretinoin—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.36e-05	0.000298	CcSEcCtD
Alitretinoin—Anorexia—Metformin—type 2 diabetes mellitus	7.35e-05	0.000297	CcSEcCtD
Alitretinoin—Cough—Losartan—type 2 diabetes mellitus	7.32e-05	0.000296	CcSEcCtD
Alitretinoin—Urticaria—Gliclazide—type 2 diabetes mellitus	7.32e-05	0.000296	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.31e-05	0.000296	CcSEcCtD
Alitretinoin—Alopecia—Ramipril—type 2 diabetes mellitus	7.3e-05	0.000296	CcSEcCtD
Alitretinoin—Fatigue—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000295	CcSEcCtD
Alitretinoin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.29e-05	0.000295	CcSEcCtD
Alitretinoin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.29e-05	0.000295	CcSEcCtD
Alitretinoin—Oedema—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000294	CcSEcCtD
Alitretinoin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000294	CcSEcCtD
Alitretinoin—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.27e-05	0.000294	CcSEcCtD
Alitretinoin—Pruritus—Glyburide—type 2 diabetes mellitus	7.26e-05	0.000294	CcSEcCtD
Alitretinoin—Mental disorder—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000293	CcSEcCtD
Alitretinoin—Constipation—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000293	CcSEcCtD
Alitretinoin—Infection—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.000292	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000292	CcSEcCtD
Alitretinoin—Fatigue—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000292	CcSEcCtD
Alitretinoin—Hypotension—Metformin—type 2 diabetes mellitus	7.21e-05	0.000292	CcSEcCtD
Alitretinoin—Erythema—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000291	CcSEcCtD
Alitretinoin—Malnutrition—Ramipril—type 2 diabetes mellitus	7.2e-05	0.000291	CcSEcCtD
Alitretinoin—Shock—Irbesartan—type 2 diabetes mellitus	7.16e-05	0.00029	CcSEcCtD
Alitretinoin—Pain—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000289	CcSEcCtD
Alitretinoin—Chest pain—Losartan—type 2 diabetes mellitus	7.14e-05	0.000289	CcSEcCtD
Alitretinoin—Myalgia—Losartan—type 2 diabetes mellitus	7.14e-05	0.000289	CcSEcCtD
Alitretinoin—Arthralgia—Losartan—type 2 diabetes mellitus	7.14e-05	0.000289	CcSEcCtD
Alitretinoin—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.14e-05	0.000289	CcSEcCtD
Alitretinoin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.14e-05	0.000289	CcSEcCtD
Alitretinoin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.13e-05	0.000288	CcSEcCtD
Alitretinoin—Anxiety—Losartan—type 2 diabetes mellitus	7.12e-05	0.000288	CcSEcCtD
Alitretinoin—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000287	CcSEcCtD
Alitretinoin—Rash—Bromocriptine—type 2 diabetes mellitus	7.08e-05	0.000286	CcSEcCtD
Alitretinoin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.07e-05	0.000286	CcSEcCtD
Alitretinoin—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000286	CcSEcCtD
Alitretinoin—Tension—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000286	CcSEcCtD
Alitretinoin—Discomfort—Losartan—type 2 diabetes mellitus	7.06e-05	0.000286	CcSEcCtD
Alitretinoin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.04e-05	0.000285	CcSEcCtD
Alitretinoin—Headache—Bromocriptine—type 2 diabetes mellitus	7.03e-05	0.000285	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.03e-05	0.000284	CcSEcCtD
Alitretinoin—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.02e-05	0.000284	CcSEcCtD
Alitretinoin—Nervousness—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000283	CcSEcCtD
Alitretinoin—Dry mouth—Losartan—type 2 diabetes mellitus	6.99e-05	0.000283	CcSEcCtD
Alitretinoin—Anorexia—Irbesartan—type 2 diabetes mellitus	6.94e-05	0.000281	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.93e-05	0.00028	CcSEcCtD
Alitretinoin—Paraesthesia—Metformin—type 2 diabetes mellitus	6.93e-05	0.00028	CcSEcCtD
Alitretinoin—Confusional state—Losartan—type 2 diabetes mellitus	6.91e-05	0.000279	CcSEcCtD
Alitretinoin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.9e-05	0.000279	CcSEcCtD
Alitretinoin—Dyspnoea—Metformin—type 2 diabetes mellitus	6.88e-05	0.000278	CcSEcCtD
Alitretinoin—Somnolence—Metformin—type 2 diabetes mellitus	6.86e-05	0.000277	CcSEcCtD
Alitretinoin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	6.85e-05	0.000277	CcSEcCtD
Alitretinoin—Oedema—Losartan—type 2 diabetes mellitus	6.85e-05	0.000277	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.84e-05	0.000277	CcSEcCtD
Alitretinoin—Infection—Losartan—type 2 diabetes mellitus	6.8e-05	0.000275	CcSEcCtD
Alitretinoin—Hypotension—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000275	CcSEcCtD
Alitretinoin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.79e-05	0.000275	CcSEcCtD
Alitretinoin—Dyspepsia—Metformin—type 2 diabetes mellitus	6.79e-05	0.000275	CcSEcCtD
Alitretinoin—Tremor—Ramipril—type 2 diabetes mellitus	6.74e-05	0.000273	CcSEcCtD
Alitretinoin—Shock—Losartan—type 2 diabetes mellitus	6.74e-05	0.000273	CcSEcCtD
Alitretinoin—Urticaria—Valsartan—type 2 diabetes mellitus	6.73e-05	0.000272	CcSEcCtD
Alitretinoin—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.72e-05	0.000272	CcSEcCtD
Alitretinoin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.71e-05	0.000271	CcSEcCtD
Alitretinoin—Decreased appetite—Metformin—type 2 diabetes mellitus	6.7e-05	0.000271	CcSEcCtD
Alitretinoin—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.69e-05	0.000271	CcSEcCtD
Alitretinoin—Tachycardia—Losartan—type 2 diabetes mellitus	6.68e-05	0.00027	CcSEcCtD
Alitretinoin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.68e-05	0.00027	CcSEcCtD
Alitretinoin—Nausea—Bromocriptine—type 2 diabetes mellitus	6.67e-05	0.00027	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.66e-05	0.000269	CcSEcCtD
Alitretinoin—Fatigue—Metformin—type 2 diabetes mellitus	6.65e-05	0.000269	CcSEcCtD
Alitretinoin—Urticaria—Orlistat—type 2 diabetes mellitus	6.65e-05	0.000269	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000268	CcSEcCtD
Alitretinoin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.62e-05	0.000268	CcSEcCtD
Alitretinoin—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.62e-05	0.000268	CcSEcCtD
Alitretinoin—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.62e-05	0.000268	CcSEcCtD
Alitretinoin—Asthenia—Gliclazide—type 2 diabetes mellitus	6.61e-05	0.000268	CcSEcCtD
Alitretinoin—Agitation—Ramipril—type 2 diabetes mellitus	6.61e-05	0.000268	CcSEcCtD
Alitretinoin—Constipation—Metformin—type 2 diabetes mellitus	6.6e-05	0.000267	CcSEcCtD
Alitretinoin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000264	CcSEcCtD
Alitretinoin—Anorexia—Losartan—type 2 diabetes mellitus	6.53e-05	0.000264	CcSEcCtD
Alitretinoin—Vomiting—Glyburide—type 2 diabetes mellitus	6.53e-05	0.000264	CcSEcCtD
Alitretinoin—Pruritus—Gliclazide—type 2 diabetes mellitus	6.52e-05	0.000264	CcSEcCtD
Alitretinoin—Malaise—Ramipril—type 2 diabetes mellitus	6.49e-05	0.000263	CcSEcCtD
Alitretinoin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.49e-05	0.000262	CcSEcCtD
Alitretinoin—Rash—Glyburide—type 2 diabetes mellitus	6.47e-05	0.000262	CcSEcCtD
Alitretinoin—Somnolence—Irbesartan—type 2 diabetes mellitus	6.47e-05	0.000262	CcSEcCtD
Alitretinoin—Dermatitis—Glyburide—type 2 diabetes mellitus	6.47e-05	0.000262	CcSEcCtD
Alitretinoin—Syncope—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000261	CcSEcCtD
Alitretinoin—Headache—Glyburide—type 2 diabetes mellitus	6.43e-05	0.00026	CcSEcCtD
Alitretinoin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.41e-05	0.000259	CcSEcCtD
Alitretinoin—Hypotension—Losartan—type 2 diabetes mellitus	6.4e-05	0.000259	CcSEcCtD
Alitretinoin—Palpitations—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000257	CcSEcCtD
Alitretinoin—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.36e-05	0.000257	CcSEcCtD
Alitretinoin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000256	CcSEcCtD
Alitretinoin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000256	CcSEcCtD
Alitretinoin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.31e-05	0.000255	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.31e-05	0.000255	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000254	CcSEcCtD
Alitretinoin—Cough—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000254	CcSEcCtD
Alitretinoin—Fatigue—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000254	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.24e-05	0.000252	CcSEcCtD
Alitretinoin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.24e-05	0.000252	CcSEcCtD
Alitretinoin—Convulsion—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000252	CcSEcCtD
Alitretinoin—Pain—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000252	CcSEcCtD
Alitretinoin—Constipation—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000252	CcSEcCtD
Alitretinoin—Insomnia—Losartan—type 2 diabetes mellitus	6.19e-05	0.000251	CcSEcCtD
Alitretinoin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000249	CcSEcCtD
Alitretinoin—Paraesthesia—Losartan—type 2 diabetes mellitus	6.15e-05	0.000249	CcSEcCtD
Alitretinoin—Urticaria—Metformin—type 2 diabetes mellitus	6.13e-05	0.000248	CcSEcCtD
Alitretinoin—Arthralgia—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000248	CcSEcCtD
Alitretinoin—Myalgia—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000248	CcSEcCtD
Alitretinoin—Chest pain—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000248	CcSEcCtD
Alitretinoin—Dyspnoea—Losartan—type 2 diabetes mellitus	6.11e-05	0.000247	CcSEcCtD
Alitretinoin—Anxiety—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000247	CcSEcCtD
Alitretinoin—Nausea—Glyburide—type 2 diabetes mellitus	6.1e-05	0.000247	CcSEcCtD
Alitretinoin—Abdominal pain—Metformin—type 2 diabetes mellitus	6.1e-05	0.000247	CcSEcCtD
Alitretinoin—Dizziness—Gliclazide—type 2 diabetes mellitus	6.1e-05	0.000247	CcSEcCtD
Alitretinoin—Somnolence—Losartan—type 2 diabetes mellitus	6.09e-05	0.000246	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000246	CcSEcCtD
Alitretinoin—Asthenia—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000246	CcSEcCtD
Alitretinoin—Discomfort—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000245	CcSEcCtD
Alitretinoin—Dyspepsia—Losartan—type 2 diabetes mellitus	6.03e-05	0.000244	CcSEcCtD
Alitretinoin—Asthenia—Orlistat—type 2 diabetes mellitus	6e-05	0.000243	CcSEcCtD
Alitretinoin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6e-05	0.000243	CcSEcCtD
Alitretinoin—Pruritus—Valsartan—type 2 diabetes mellitus	5.99e-05	0.000242	CcSEcCtD
Alitretinoin—Dry mouth—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000242	CcSEcCtD
Alitretinoin—Decreased appetite—Losartan—type 2 diabetes mellitus	5.95e-05	0.000241	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000241	CcSEcCtD
Alitretinoin—Confusional state—Ramipril—type 2 diabetes mellitus	5.92e-05	0.00024	CcSEcCtD
Alitretinoin—Pruritus—Orlistat—type 2 diabetes mellitus	5.92e-05	0.00024	CcSEcCtD
Alitretinoin—Fatigue—Losartan—type 2 diabetes mellitus	5.91e-05	0.000239	CcSEcCtD
Alitretinoin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000238	CcSEcCtD
Alitretinoin—Oedema—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000238	CcSEcCtD
Alitretinoin—Vomiting—Gliclazide—type 2 diabetes mellitus	5.86e-05	0.000237	CcSEcCtD
Alitretinoin—Constipation—Losartan—type 2 diabetes mellitus	5.86e-05	0.000237	CcSEcCtD
Alitretinoin—Pain—Losartan—type 2 diabetes mellitus	5.86e-05	0.000237	CcSEcCtD
Alitretinoin—Rash—Gliclazide—type 2 diabetes mellitus	5.81e-05	0.000235	CcSEcCtD
Alitretinoin—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.81e-05	0.000235	CcSEcCtD
Alitretinoin—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.79e-05	0.000234	CcSEcCtD
Alitretinoin—Urticaria—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000234	CcSEcCtD
Alitretinoin—Shock—Ramipril—type 2 diabetes mellitus	5.78e-05	0.000234	CcSEcCtD
Alitretinoin—Headache—Gliclazide—type 2 diabetes mellitus	5.77e-05	0.000234	CcSEcCtD
Alitretinoin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.76e-05	0.000233	CcSEcCtD
Alitretinoin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000233	CcSEcCtD
Alitretinoin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.75e-05	0.000233	CcSEcCtD
Alitretinoin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000233	CcSEcCtD
Alitretinoin—Tachycardia—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000232	CcSEcCtD
Alitretinoin—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.73e-05	0.000232	CcSEcCtD
Alitretinoin—Skin disorder—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000231	CcSEcCtD
Alitretinoin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.68e-05	0.00023	CcSEcCtD
Alitretinoin—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.64e-05	0.000228	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.6e-05	0.000227	CcSEcCtD
Alitretinoin—Dizziness—Valsartan—type 2 diabetes mellitus	5.6e-05	0.000227	CcSEcCtD
Alitretinoin—Anorexia—Ramipril—type 2 diabetes mellitus	5.6e-05	0.000226	CcSEcCtD
Alitretinoin—Dizziness—Orlistat—type 2 diabetes mellitus	5.53e-05	0.000224	CcSEcCtD
Alitretinoin—Asthenia—Metformin—type 2 diabetes mellitus	5.53e-05	0.000224	CcSEcCtD
Alitretinoin—Hypotension—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000222	CcSEcCtD
Alitretinoin—Nausea—Gliclazide—type 2 diabetes mellitus	5.48e-05	0.000221	CcSEcCtD
Alitretinoin—Pruritus—Metformin—type 2 diabetes mellitus	5.46e-05	0.000221	CcSEcCtD
Alitretinoin—Urticaria—Losartan—type 2 diabetes mellitus	5.44e-05	0.00022	CcSEcCtD
Alitretinoin—Body temperature increased—Losartan—type 2 diabetes mellitus	5.41e-05	0.000219	CcSEcCtD
Alitretinoin—Abdominal pain—Losartan—type 2 diabetes mellitus	5.41e-05	0.000219	CcSEcCtD
Alitretinoin—Vomiting—Valsartan—type 2 diabetes mellitus	5.38e-05	0.000218	CcSEcCtD
Alitretinoin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000217	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000216	CcSEcCtD
Alitretinoin—Rash—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000216	CcSEcCtD
Alitretinoin—Dermatitis—Valsartan—type 2 diabetes mellitus	5.33e-05	0.000216	CcSEcCtD
Alitretinoin—Vomiting—Orlistat—type 2 diabetes mellitus	5.32e-05	0.000215	CcSEcCtD
Alitretinoin—Insomnia—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000215	CcSEcCtD
Alitretinoin—Headache—Valsartan—type 2 diabetes mellitus	5.31e-05	0.000215	CcSEcCtD
Alitretinoin—Diarrhoea—Metformin—type 2 diabetes mellitus	5.28e-05	0.000213	CcSEcCtD
Alitretinoin—Rash—Orlistat—type 2 diabetes mellitus	5.28e-05	0.000213	CcSEcCtD
Alitretinoin—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000213	CcSEcCtD
Alitretinoin—Dermatitis—Orlistat—type 2 diabetes mellitus	5.27e-05	0.000213	CcSEcCtD
Alitretinoin—Headache—Orlistat—type 2 diabetes mellitus	5.24e-05	0.000212	CcSEcCtD
Alitretinoin—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.24e-05	0.000212	CcSEcCtD
Alitretinoin—Asthenia—Irbesartan—type 2 diabetes mellitus	5.22e-05	0.000211	CcSEcCtD
Alitretinoin—Somnolence—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000211	CcSEcCtD
Alitretinoin—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000209	CcSEcCtD
Alitretinoin—Pruritus—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.000208	CcSEcCtD
Alitretinoin—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000207	CcSEcCtD
Alitretinoin—Dizziness—Metformin—type 2 diabetes mellitus	5.1e-05	0.000206	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.07e-05	0.000205	CcSEcCtD
Alitretinoin—Fatigue—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000205	CcSEcCtD
Alitretinoin—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.05e-05	0.000204	CcSEcCtD
Alitretinoin—Nausea—Valsartan—type 2 diabetes mellitus	5.03e-05	0.000203	CcSEcCtD
Alitretinoin—Constipation—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000203	CcSEcCtD
Alitretinoin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000201	CcSEcCtD
Alitretinoin—Nausea—Orlistat—type 2 diabetes mellitus	4.97e-05	0.000201	CcSEcCtD
Alitretinoin—Asthenia—Losartan—type 2 diabetes mellitus	4.91e-05	0.000199	CcSEcCtD
Alitretinoin—Vomiting—Metformin—type 2 diabetes mellitus	4.9e-05	0.000198	CcSEcCtD
Alitretinoin—Rash—Metformin—type 2 diabetes mellitus	4.86e-05	0.000197	CcSEcCtD
Alitretinoin—Dermatitis—Metformin—type 2 diabetes mellitus	4.86e-05	0.000197	CcSEcCtD
Alitretinoin—Pruritus—Losartan—type 2 diabetes mellitus	4.85e-05	0.000196	CcSEcCtD
Alitretinoin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000196	CcSEcCtD
Alitretinoin—Headache—Metformin—type 2 diabetes mellitus	4.83e-05	0.000195	CcSEcCtD
Alitretinoin—Dizziness—Irbesartan—type 2 diabetes mellitus	4.81e-05	0.000195	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000194	CcSEcCtD
Alitretinoin—Diarrhoea—Losartan—type 2 diabetes mellitus	4.69e-05	0.00019	CcSEcCtD
Alitretinoin—Urticaria—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000189	CcSEcCtD
Alitretinoin—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000188	CcSEcCtD
Alitretinoin—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.64e-05	0.000188	CcSEcCtD
Alitretinoin—Vomiting—Irbesartan—type 2 diabetes mellitus	4.63e-05	0.000187	CcSEcCtD
Alitretinoin—Rash—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000186	CcSEcCtD
Alitretinoin—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000185	CcSEcCtD
Alitretinoin—Nausea—Metformin—type 2 diabetes mellitus	4.58e-05	0.000185	CcSEcCtD
Alitretinoin—Headache—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000184	CcSEcCtD
Alitretinoin—Dizziness—Losartan—type 2 diabetes mellitus	4.53e-05	0.000183	CcSEcCtD
Alitretinoin—Vomiting—Losartan—type 2 diabetes mellitus	4.35e-05	0.000176	CcSEcCtD
Alitretinoin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000175	CcSEcCtD
Alitretinoin—Nausea—Irbesartan—type 2 diabetes mellitus	4.32e-05	0.000175	CcSEcCtD
Alitretinoin—Rash—Losartan—type 2 diabetes mellitus	4.32e-05	0.000175	CcSEcCtD
Alitretinoin—Dermatitis—Losartan—type 2 diabetes mellitus	4.31e-05	0.000175	CcSEcCtD
Alitretinoin—Headache—Losartan—type 2 diabetes mellitus	4.29e-05	0.000174	CcSEcCtD
Alitretinoin—Asthenia—Ramipril—type 2 diabetes mellitus	4.21e-05	0.00017	CcSEcCtD
Alitretinoin—Pruritus—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000168	CcSEcCtD
Alitretinoin—Nausea—Losartan—type 2 diabetes mellitus	4.07e-05	0.000165	CcSEcCtD
Alitretinoin—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000163	CcSEcCtD
Alitretinoin—Dizziness—Ramipril—type 2 diabetes mellitus	3.88e-05	0.000157	CcSEcCtD
Alitretinoin—Vomiting—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000151	CcSEcCtD
Alitretinoin—Rash—Ramipril—type 2 diabetes mellitus	3.7e-05	0.00015	CcSEcCtD
Alitretinoin—Dermatitis—Ramipril—type 2 diabetes mellitus	3.7e-05	0.00015	CcSEcCtD
Alitretinoin—Headache—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000149	CcSEcCtD
Alitretinoin—Nausea—Ramipril—type 2 diabetes mellitus	3.49e-05	0.000141	CcSEcCtD
Alitretinoin—RXRA—Metabolism—CYP2E1—type 2 diabetes mellitus	1.19e-05	6.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A2—type 2 diabetes mellitus	1.17e-05	6.86e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC2A1—type 2 diabetes mellitus	1.17e-05	6.86e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.17e-05	6.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	1.17e-05	6.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	1.15e-05	6.7e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP3A4—type 2 diabetes mellitus	1.15e-05	6.69e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.14e-05	6.65e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.13e-05	6.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.13e-05	6.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.13e-05	6.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.13e-05	6.6e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.13e-05	6.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCG—type 2 diabetes mellitus	1.13e-05	6.57e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC2A4—type 2 diabetes mellitus	1.13e-05	6.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGDS—type 2 diabetes mellitus	1.12e-05	6.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AANAT—type 2 diabetes mellitus	1.12e-05	6.54e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—type 2 diabetes mellitus	1.12e-05	6.53e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NFKB1—type 2 diabetes mellitus	1.11e-05	6.47e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.09e-05	6.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.09e-05	6.37e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR3C1—type 2 diabetes mellitus	1.07e-05	6.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.07e-05	6.22e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.06e-05	6.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CDO1—type 2 diabetes mellitus	1.06e-05	6.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPD2—type 2 diabetes mellitus	1.06e-05	6.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.05e-05	6.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.04e-05	6.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.03e-05	6.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.03e-05	6.04e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SRC—type 2 diabetes mellitus	1.03e-05	6.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.03e-05	6.02e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AK1—type 2 diabetes mellitus	1.01e-05	5.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.01e-05	5.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.01e-05	5.88e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—type 2 diabetes mellitus	1e-05	5.87e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARA—type 2 diabetes mellitus	1e-05	5.86e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1e-05	5.85e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	1e-05	5.84e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GNB3—type 2 diabetes mellitus	9.7e-06	5.67e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.7e-06	5.67e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMOX1—type 2 diabetes mellitus	9.66e-06	5.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	9.61e-06	5.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	9.61e-06	5.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	9.61e-06	5.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	9.61e-06	5.61e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAT—type 2 diabetes mellitus	9.53e-06	5.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	9.46e-06	5.53e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A4—type 2 diabetes mellitus	9.34e-06	5.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MAT1A—type 2 diabetes mellitus	9.34e-06	5.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	9.3e-06	5.43e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOB—type 2 diabetes mellitus	9.25e-06	5.4e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—type 2 diabetes mellitus	9.22e-06	5.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	9.21e-06	5.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	9.21e-06	5.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	9.13e-06	5.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	9.05e-06	5.28e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—type 2 diabetes mellitus	9.04e-06	5.28e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HBA2—type 2 diabetes mellitus	9.02e-06	5.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ENPP1—type 2 diabetes mellitus	9.02e-06	5.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPP1R3C—type 2 diabetes mellitus	9.02e-06	5.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—G6PC—type 2 diabetes mellitus	9.02e-06	5.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ND1—type 2 diabetes mellitus	9.02e-06	5.27e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—type 2 diabetes mellitus	9e-06	5.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	8.87e-06	5.18e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	8.87e-06	5.18e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LPL—type 2 diabetes mellitus	8.83e-06	5.16e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	8.82e-06	5.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCGR—type 2 diabetes mellitus	8.74e-06	5.1e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	8.71e-06	5.09e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ADCY5—type 2 diabetes mellitus	8.65e-06	5.05e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPX1—type 2 diabetes mellitus	8.62e-06	5.03e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—type 2 diabetes mellitus	8.61e-06	5.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	8.59e-06	5.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	8.56e-06	5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	8.56e-06	5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	8.56e-06	5e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—type 2 diabetes mellitus	8.42e-06	4.92e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—type 2 diabetes mellitus	8.42e-06	4.92e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CD36—type 2 diabetes mellitus	8.39e-06	4.9e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—type 2 diabetes mellitus	8.29e-06	4.84e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPP2CA—type 2 diabetes mellitus	8.29e-06	4.84e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	8.28e-06	4.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYTB—type 2 diabetes mellitus	8.25e-06	4.82e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—OXCT1—type 2 diabetes mellitus	8.25e-06	4.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.24e-06	4.81e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.17e-06	4.77e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	8.05e-06	4.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SRD5A1—type 2 diabetes mellitus	8.04e-06	4.7e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—type 2 diabetes mellitus	7.95e-06	4.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	7.89e-06	4.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	7.88e-06	4.6e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARA—type 2 diabetes mellitus	7.8e-06	4.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	7.73e-06	4.51e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	7.67e-06	4.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	7.67e-06	4.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	7.67e-06	4.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AGT—type 2 diabetes mellitus	7.56e-06	4.41e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	7.54e-06	4.4e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—type 2 diabetes mellitus	7.47e-06	4.36e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CALM1—type 2 diabetes mellitus	7.43e-06	4.34e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—type 2 diabetes mellitus	7.4e-06	4.32e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.38e-06	4.31e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	7.36e-06	4.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	7.35e-06	4.29e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	7.35e-06	4.29e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOA1—type 2 diabetes mellitus	7.32e-06	4.27e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—type 2 diabetes mellitus	7.32e-06	4.27e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	7.28e-06	4.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.28e-06	4.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.28e-06	4.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	7.28e-06	4.25e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	7.08e-06	4.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	7.08e-06	4.13e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	6.98e-06	4.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	6.95e-06	4.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	6.95e-06	4.06e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—type 2 diabetes mellitus	6.95e-06	4.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	6.84e-06	3.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	6.84e-06	3.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	6.84e-06	3.99e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—type 2 diabetes mellitus	6.69e-06	3.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.66e-06	3.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.63e-06	3.87e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—type 2 diabetes mellitus	6.56e-06	3.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	6.49e-06	3.79e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—type 2 diabetes mellitus	6.45e-06	3.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	6.43e-06	3.75e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—type 2 diabetes mellitus	6.41e-06	3.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.33e-06	3.7e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—INS—type 2 diabetes mellitus	6.33e-06	3.69e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—type 2 diabetes mellitus	6.29e-06	3.67e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—type 2 diabetes mellitus	6.29e-06	3.67e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.25e-06	3.65e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.17e-06	3.61e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.06e-06	3.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	6.02e-06	3.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	6.01e-06	3.51e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	5.94e-06	3.47e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	5.94e-06	3.47e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	5.82e-06	3.4e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	5.81e-06	3.39e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	5.81e-06	3.39e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	5.81e-06	3.39e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	5.81e-06	3.39e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—type 2 diabetes mellitus	5.8e-06	3.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	5.79e-06	3.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	5.79e-06	3.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	5.79e-06	3.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	5.75e-06	3.36e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	5.65e-06	3.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.59e-06	3.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	5.58e-06	3.26e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	5.57e-06	3.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—type 2 diabetes mellitus	5.55e-06	3.24e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3R1—type 2 diabetes mellitus	5.55e-06	3.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.48e-06	3.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.41e-06	3.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.3e-06	3.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.24e-06	3.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.19e-06	3.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.19e-06	3.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.19e-06	3.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	5.18e-06	3.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.09e-06	2.97e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—type 2 diabetes mellitus	5.07e-06	2.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.05e-06	2.95e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.95e-06	2.89e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	4.94e-06	2.88e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.84e-06	2.82e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	4.75e-06	2.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.74e-06	2.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.74e-06	2.77e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	4.69e-06	2.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	4.69e-06	2.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.65e-06	2.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.62e-06	2.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.62e-06	2.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.62e-06	2.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.62e-06	2.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.59e-06	2.68e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.58e-06	2.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.51e-06	2.63e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.5e-06	2.63e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.5e-06	2.63e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.46e-06	2.6e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.15e-06	2.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	4.14e-06	2.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	4.14e-06	2.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	4.14e-06	2.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	4.07e-06	2.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	4.03e-06	2.35e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.97e-06	2.32e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.94e-06	2.3e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.88e-06	2.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.88e-06	2.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.86e-06	2.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.81e-06	2.22e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.79e-06	2.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.75e-06	2.19e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.7e-06	2.16e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.65e-06	2.13e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.63e-06	2.12e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.6e-06	2.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.59e-06	2.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.59e-06	2.1e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.53e-06	2.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.46e-06	2.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.44e-06	2.01e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.35e-06	1.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.31e-06	1.93e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—type 2 diabetes mellitus	3.28e-06	1.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.18e-06	1.86e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.12e-06	1.82e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.1e-06	1.81e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	3.1e-06	1.81e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.08e-06	1.8e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	3.04e-06	1.78e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.02e-06	1.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.97e-06	1.73e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.96e-06	1.73e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.95e-06	1.72e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.93e-06	1.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.87e-06	1.68e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.82e-06	1.65e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.76e-06	1.61e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.75e-06	1.61e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.68e-06	1.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.64e-06	1.54e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.58e-06	1.51e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—type 2 diabetes mellitus	2.55e-06	1.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.54e-06	1.48e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.53e-06	1.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.49e-06	1.45e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.41e-06	1.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.37e-06	1.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.36e-06	1.38e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.34e-06	1.36e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.32e-06	1.35e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.22e-06	1.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.22e-06	1.29e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.06e-06	1.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.03e-06	1.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.02e-06	1.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.85e-06	1.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.77e-06	1.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.77e-06	1.03e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.62e-06	9.45e-06	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	5.95e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.14e-07	4.75e-06	CbGpPWpGaD
